4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-25-033682
Chief Financial Officer acquired 5,023 shares (option exercise)
- Chief Financial Officer acquired 20,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2025-11-04 | Option exercise | +20,625 | 308,212 | D | ||
| Foster Jonathan P. Chief Financial Officer | 2025-11-04 | Option exercise | −5,023 | $0.50 | $2,496 | 303,189 | D |
| Derivatives | |||||||
| Foster Jonathan P. Chief Financial Officer | 2025-11-04 | Option exercise · Restricted Stock Units | −20,625 | 1,017,695 | D | ||
Loading xslF345X05/rdgdoc.xml…